Paul F. Truex
2012
In 2012, Paul F. Truex earned a total compensation of $951.7K as President, CEO and Director at Anthera Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $56,066 |
|---|---|
| Option Awards | $156,810 |
| Salary | $507,883 |
| Stock Awards | $230,943 |
| Total | $951,702 |
Truex received $507.9K in salary, accounting for 53% of the total pay in 2012.
Truex also received $56.1K in non-equity incentive plan, $156.8K in option awards and $230.9K in stock awards.
Rankings
In 2012, Paul F. Truex's compensation ranked 6,320th out of 11,487 executives tracked by ExecPay. In other words, Truex earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,320 out of 11,487 | 45th |
Division Manufacturing | 2,260 out of 4,253 | 47th |
Major group Chemicals And Allied Products | 567 out of 1,203 | 53rd |
Industry group Drugs | 387 out of 925 | 58th |
Industry Pharmaceutical Preparations | 304 out of 700 | 57th |
Source: SEC filing on April 9, 2015.
Truex's colleagues
We found five more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2012.
2012
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2012
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2012
Christopher Lowe
Anthera Pharmaceuticals
Chief Financial Officer
2012
Georgina Kilfoil
Anthera Pharmaceuticals
Senior Vice President, Product Development
2012
May Liu
Anthera Pharmaceuticals